Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Etubics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Etubics

Etubics

Series A

Seattle-based Etubics Corp. develops safer, efficient immunotherapies and vaccines using patented technology.

HQ
Seattle, WA, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Etubics Corporation, based in Seattle, Washington, is a biopharmaceutical company focused on developing targeted immunotherapies and vaccine products for resilient diseases. Utilizing patented technology, Etubics aims to create safer, more efficient, and effective solutions compared to current vectored vaccines and gene delivery platforms.

Etubics has achieved significant milestones, including the development of ANKTIVA®, a first-in-class immunotherapy for non-muscle invasive bladder cancer. The company collaborates with notable entities like ImmunityBio and the Serum Institute of India to advance large-scale manufacturing and clinical trials, underscoring its impact in the biopharmaceutical industry.

Etubics - Similar Companies

Ubivac logo

Ubivac

ubivac.com

Abacus Bioscience logo

Abacus Bioscience

Inimmune logo

Inimmune

inimmune.com

Nantkwest logo

Nantkwest

IBT Vaccines logo

IBT Vaccines

ImmunityBio logo

ImmunityBio

immunitybio.com

Therabiol logo

Therabiol

Agilvax logo

Agilvax

EpicentRx logo

EpicentRx

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

Epivax logo

Epivax

epivax.com

Northwest Biotherapeutics logo

Northwest Biotherapeutics

nwbio.com

Immunomic Therapeutics logo

Immunomic Therapeutics

immunomix.com

Cleveland BioLabs logo

Cleveland BioLabs

LTZ Therapeutics logo

LTZ Therapeutics

Etubics - Quick Facts

Who are Etubics' competitors?

Companies similar to Etubics include Ubivac, Abacus Bioscience, Inimmune and Nantkwest.

When was Etubics founded?

Etubics was founded in 2003.

Where is Etubics' headquarters located?

Etubics' headquarters is located in Seattle, WA, US.

When was Etubics' last funding round?

Etubics' most recent funding round was for $4.4M (USD) in April 2014.

How much has Etubics raised to-date?

As of Apr 30, 2014, Etubics has raised a total of $4.4M (USD).

How many employees does Etubics have?

Etubics has 8 employees as of Feb 4, 2024.

Etubics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapy
  • Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified